David Coeffic
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 26
- Cancer Treatment and Pharmacology 17
- HER2/EGFR in Cancer Research 12
- Colorectal Cancer Treatments and Studies 3
- Neutropenia and Cancer Infections 3
-
- Breast Cancer Treatment Studies 14
- Co-authors
- Laurent Arnould (6 shared papers)David Khayat (2 shared papers)Bruno Coudert (6 shared papers)Éric-Charles Antoine (1 shared paper)Mario Campone (3 shared papers)Joseph Gligorov (3 shared papers)P. Chollet (2 shared papers)Frank Priou (2 shared papers)
In The Last Decade
David Coeffic
33 papers receiving 453 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 180
- Oncology 311
- Reproductive Medicine 51
- Radiology, Nuclear Medicine and Imaging 116
- Obstetrics and Gynecology 21
Countries citing papers authored by David Coeffic
This map shows the geographic impact of David Coeffic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Coeffic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Coeffic more than expected).
Fields of papers citing papers by David Coeffic
This network shows the impact of papers produced by David Coeffic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Coeffic. The network helps show where David Coeffic may publish in the future.
Co-authors
The 25 scholars most cited alongside David Coeffic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 102 | |
| 2 | 2014 | 97 | |
| 3 | 2000 | 37 | |
| 4 | 2011 | 28 | |
| 5 | 2012 | 27 | |
| 6 | 2012 | 22 | |
| 7 | 2016 | 22 | |
| 8 | 2001 | 21 | |
| 9 | 2010 | 17 | |
| 10 | 2015 | 14 | |
| 11 | 2006 | 12 | |
| 12 | 2011 | 12 | |
| 13 | 2020 | 7 | |
| 14 | Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances. | 2000 | 6 |
| 15 | European experience with irinotecan plus fluorouracil/folinic acid or mitomycin. | 1998 | 5 |
| 16 | 2011 | 4 | |
| 17 | 2006 | 4 | |
| 18 | Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma. | 1997 | 4 |
| 19 | 2013 | 4 | |
| 20 | 2011 | 3 |
About David Coeffic
David Coeffic is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (17 papers), Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (12 papers), Ovarian cancer diagnosis and treatment (6 papers), Colorectal Cancer Treatments and Studies (3 papers), Neutropenia and Cancer Infections (3 papers), Intraperitoneal and Appendiceal Malignancies (3 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (180 citations), Oncology (311 citations), Reproductive Medicine (51 citations), Radiology, Nuclear Medicine and Imaging (116 citations) and Obstetrics and Gynecology (21 citations). David Coeffic has collaborated with scholars based in France, Italy and Australia. Frequent co-authors include Laurent Arnould, David Khayat, Bruno Coudert, Éric-Charles Antoine, Mario Campone, Joseph Gligorov, P. Chollet, Frank Priou, V. Trillet-Lenoir and B. Weber. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.